Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QTL Biodetection
Santa Fe, New Mexico, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The company launched portable biosensors and disposable cartridges for rapid field detection of biological threats such as ricin and anthrax. The systems demonstrated high sensitivity and a low false positive rate in validation studies with US Army and other agencies. No recent clinical or market activity documented.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceImmunoassayBiosensor
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
U.S. Army Edgewood Chemical Biological CommandMSA (distribution partner for BIOSENSOR 2200R)
Beyond the preview
Go deeper on QTL Biodetection.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QTL Biodetection.